BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2458646)

  • 1. Cytokeratin immunocytochemistry in the practice of diagnostic histopathology.
    Viale G
    Ultrastruct Pathol; 1988; 12(4):iii-vii. PubMed ID: 2458646
    [No Abstract]   [Full Text] [Related]  

  • 2. Vimentin: an evaluation of its role as a tumour marker.
    Leader M; Collins M; Patel J; Henry K
    Histopathology; 1987 Jan; 11(1):63-72. PubMed ID: 2435649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemistry of anaplastic carcinoma of thyroid gland.
    Beltrami CA; Criante P; Di Loreto C
    Appl Pathol; 1989; 7(2):122-33. PubMed ID: 2471539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications, and limitations.
    Cooper D; Schermer A; Sun TT
    Lab Invest; 1985 Mar; 52(3):243-56. PubMed ID: 2579289
    [No Abstract]   [Full Text] [Related]  

  • 5. An immunohistochemical study of difference between cervical and endometrial adenocarcinomas of the uterus--using monoclonal antibodies of vimentin and cytokeratin.
    Jinnouchi H
    Fukushima J Med Sci; 1987 Dec; 33(2):85-108. PubMed ID: 2471680
    [No Abstract]   [Full Text] [Related]  

  • 6. A panel of monoclonal antibodies to keratin no. 7: characterization and value in tumor diagnosis.
    Vojtĕsek B; Stasková Z; Nenutil R; Bártková J; Kovarík J; Rejthar A; Bártek J
    Neoplasma; 1990; 37(3):333-42. PubMed ID: 1695327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid immunocytochemistry for the detection of cytokeratin and vimentin: assessment of its diagnostic value in neoplastic diseases of dogs.
    Sawa M; Inoue M; Yabuki A; Kohyama M; Miyoshi N; Setoguchi A; Yamato O
    Vet Clin Pathol; 2017 Mar; 46(1):172-178. PubMed ID: 28186651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of different cytokeratin subclasses in human chordoma.
    Heikinheimo K; Persson S; Kindblom LG; Morgan PR; Virtanen I
    J Pathol; 1991 Jun; 164(2):145-50. PubMed ID: 1712838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of cytokeratin/vimentin coexpression in the guinea pig.
    Kasper M
    Acta Histochem; 1989; 86(1):85-91. PubMed ID: 2475999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression of cytokeratin and vimentin.
    McGuire LJ; Ng JP; Lee JC
    Appl Pathol; 1989; 7(2):73-84. PubMed ID: 2471541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cytokeratins and vimentin in salivary gland carcinomas as revealed with monoclonal antibodies.
    Gustafsson H; Virtanen I; Thornell LE
    Virchows Arch A Pathol Anat Histopathol; 1988; 412(6):515-24. PubMed ID: 2452508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative evaluation of immunohistochemical markers for the differential diagnosis of malignant pleural tumours.
    Garcia-Prats MD; Ballestin C; Sotelo T; Lopez-Encuentra A; Mayordomo JI
    Histopathology; 1998 May; 32(5):462-72. PubMed ID: 9639123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vimentin and cytokeratin expression in nodular hyperplasia and carcinoma of the prostate.
    Heatley M; Maxwell P; Whiteside C; Toner P
    J Clin Pathol; 1995 Nov; 48(11):1031-4. PubMed ID: 8543626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of vimentin and high-molecular-weight cytokeratin (clone 34ßE12) in differentiating reactive renal tubular cells from low-grade urothelial carcinoma cells in voided urine.
    Ohsaki H; Hirakawa E; Nakamura M; Norimatsu Y; Kiyomoto H; Haba R
    Cytopathology; 2011 Aug; 22(4):247-52. PubMed ID: 20653719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Main steps of immunohistochemical diagnosis of human tumors].
    Raĭkhlin NT; Petrov SV
    Arkh Patol; 1997; 59(4):14-9. PubMed ID: 9334149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid multiple immunofluorescent staining for the simultaneous detection of cytokeratin and vimentin in the cytology of canine tumors.
    Sawa M; Yabuki A; Kohyama M; Miyoshi N; Yamato O
    Vet Clin Pathol; 2018 Jun; 47(2):326-332. PubMed ID: 29522252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The distribution of vimentin and keratin in epithelial and nonepithelial neoplasms. A comprehensive immunohistochemical study on formalin- and alcohol-fixed tumors.
    Azumi N; Battifora H
    Am J Clin Pathol; 1987 Sep; 88(3):286-96. PubMed ID: 2443000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratin and vimentin expression in normal epithelium and benign lesions of the vocal cords.
    van der Velden LA; Schaafsma HE; Manni JJ; Link M; Ruiter DJ; Ramaekers FC; Kuijpers W
    Acta Otolaryngol; 1996 Mar; 116(2):325-31. PubMed ID: 8725542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo detection of apoptotic trophoblast cells applying flow cytofluorometry and immunocytochemistry using M30 antibody directed to the cytokeratin 18 neo-epitope.
    Krol J; Mengele K; Ottl-Mantchenko I; Welk A; Wasilewitsch I; von Steinburg SP; Schneider KT; Schmitt M
    Int J Mol Med; 2005 Sep; 16(3):415-20. PubMed ID: 16077948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to intermediate filament proteins as molecular markers in clinical tumor pathology. Differentiation of carcinomas by their reaction with different cytokeratin antibodies.
    Krepler R; Denk H; Artlieb U; Fichtinger E; Davidovits A
    Pathol Res Pract; 1982; 175(2-3):212-26. PubMed ID: 6190145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.